CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on July 3, 2007 under Uncategorized | Be the First to Comment
Ras as a therapeutic target in hematologic malignancies.
Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.